Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the ...

Q4 2024 Earnings Call Transcript April 1, 2025 Evaxion Biotech A/S misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.03. Operator: Good day, and thank you for standing ...

PM Narendra Modi, industrialist Ratan Tata, biotech pioneer Raj Bhan, and mathematician Srinivasa Ramanujan. Gates recalls ...

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant funds already spent on projects ...

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...